Home > News > Techniques for Rapid Drug Discovery Now Focusing on Nanoscience Research
May 3rd, 2007
Techniques for Rapid Drug Discovery Now Focusing on Nanoscience Research
Ron Zuckermann, lead scientist for Lawrence Berkeley National Lab's Molecular Foundry Biological Nanostructures Facility, is taking the same techniques drug companies use to discover drugs to help nanoscientists cut the cost and shorten the time for their hunt for useful nano-compounds.
Dr. Zuckermann knows a lot about that proven drug-discovery process, dubbed combinatorial chemistry - he helped invent the process more than a decade ago. Before coming to the Molecular Foundry, Dr. Zuckermann worked for the biotechnology industry, and was one of the creators of the combinatorial chemistry techniques, whereby researchers create and test thousands (and in some cases millions) of compounds for just the right properties. His current LBNL work is sponsored by the Department of Energy, and is available for universities and private research arms to participate in.
Total Nanofiber Solutions Company FibeRioŽ Launches The Fiber EngineŽ FX Series Systems with 10X Increase in Output November 18th, 2014
Nanocomposites Strengthen Bone Implants November 13th, 2014
Production of Magnetic Nanoparticles with New Structures in Iran November 13th, 2014
OCSiAl Builds Worldwide Partnership Network November 12th, 2014
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
UO-industry collaboration points to improved nanomaterials: University of Oregon microscope puts spotlight on the surface structure of quantum dots for designing new solar devices November 20th, 2014
Silver Nanoparticles Produced in Iran from Forest Plants Extract November 20th, 2014
Nano Sorbents Able to Remove Pollutions Caused by Oil Derivatives November 20th, 2014
NRL Scientists Discover Novel Metamaterial Properties within Hexagonal Boron Nitride November 20th, 2014